Research Article

Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq

Table 3

Multivariate analysis for determinants of complication rate.

Complication/parametersRR95% CI

PHT
0.7980.13-4.640.801
 Splenectomy0.8390.27-2.60.762
 Transfusion0.6700.06-6.810.735
 Hydroxyurea0.6000.19-1.820.369
 Iron chelation0.1600.03-0.650.011
Cholelithiasis
1.1530.19-6.730.874
 Female1.6930.53-5.340.369
 Splenectomy0.1400.03-0.500.003
 Transfusion0.5370.05-5.270.594
 Hydroxyurea0.1790.05-0.600.006
 Iron chelation0.3250.08-1.190.09
Hypothyroidism
 y1.8170.20-16.140.592
 Splenectomy2.1780.70-6.750.178
 Transfusion0.2510.05-1.240.091
 Hydroxyurea0.6450.23-1.790.401
 Iron chelation0.5520.241-1.2650.149
Osteoporosis
0.6160.235-1.620.364
 Female4.1390.87-19.580.073
6.861.09-42.970.040
 Splenectomy0.9940.24-4.110.994
 Transfusion14.3520.86-221.120.063
 Hydroxyurea9.0041.67-48.410.010
 Iron chelation0.4430.09-2.080.302